Fujimori named to lead GEMS Asia

Article

GE has shifted its executive lineup in Asia, promoting Goran Malm to president of GE Asia-Pacific and naming Yoshiaki Fujimori to assume Malm's position as president and CEO of GE Medical Systems Asia. Fujimori was previously general manager of global

GE has shifted its executive lineup in Asia, promoting Goran Malm to president of GE Asia-Pacific and naming Yoshiaki Fujimori to assume Malm's position as president and CEO of GE Medical Systems Asia. Fujimori was previously general manager of global MRI, nuclear medicine, and PET at GE Medical Systems in Milwaukee.

Malm is credited with orchestrating the expansion of GEMS in a broad geographic region that ranges from Japan to Australia to India. In his new capacity, Malm will lead GE's international activities in the Asia-Pacific region.

Fujimori credited the MRI product development group's ability to bring new systems to market as a key to his elevation. This is Fujimori's second Asian tour of duty: He was manager of business development for GE Medical Systems Asia in 1990 when he was transferred to Milwaukee as general manager of nuclear medicine. In 1992, he was named manager of CT and radiation therapy. In February 1996, the company announced his appointment as global general manager of MRI operations.

Succeeding Fujimori as general manager of global MRI is Gene Saragnese, who was transferred to Milwaukee in late 1995 as manager of MR engineering. Fujimori's managerial duties over nuclear medicine and PET in Milwaukee were delegated to Sharon Banaszewski, who was promoted to general manager of the nuclear medicine/PET group.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.